Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,20119,220 of 20,252 grants

Completed OTHER RESEARCH-RELATED
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis Complex
NATIONAL CANCER INSTITUTE Michigan State University United States 2021 – 2025

PROJECT SUMMARYTuberous Sclerosis Complex (TSC) is a genetic syndrome that predisposes patients to tumor formation and is often diagnosed during infancy. Brain lesions, including s...

$915.6K
USD
Completed NON-SBIR/STTR RPGS
Longitudinal Spatial-Nonspatial Decision Support for Competing Outcomes in Head and Neck Cancer Therapy
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2021 – 2026

Cancers that depend on the spatial location of the disease affect all ethnicities and age groups, accounting for significant mortality and therapy-related side effects. In one inst...

$4.69M
USD
Completed NON-SBIR/STTR RPGS
Evaluation of TRPM8-expressing neurons as novel regulators of acute radiotherapy-associated pain in patients with head and neck cancer
NATIONAL CANCER INSTITUTE North Carolina State University Raleigh United States 2021 – 2026

The goal of this proposal is to define the role of each component of the ARTN/GFR3/TRPM8 signaling pathway in radiation-associated pain (RAP). A common consequence of radiotherapy...

$3.41M
USD
Completed NON-SBIR/STTR RPGS
The ASPIRES Study: Activating Cancer Survivors and their Primary Care Providers to Increase Colorectal Cancer Screening
NATIONAL CANCER INSTITUTE University of Chicago United States 2021 – 2026

Project Summary Childhood cancer survivors treated with abdominal or pelvic radiotherapy (RT) are almost four times more likely to develop colorectal cancer (CRC) compared to the g...

$6.33M
USD
Completed NON-SBIR/STTR RPGS
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

PROJECT SUMMARY Activating KRAS mutations, altered metabolism, and an immunosuppressive tumor microenvironment are all hallmarks of pancreatic ductal adenocarcinoma (PDAC). The rec...

$5.9M
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
NATIONAL CANCER INSTITUTE University of Minnesota United States 2021 – 2026

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDA) is a lethal disease notoriously resistant to therapy including immune checkpoint blockade. Meanwhile, immunotherapy targeting...

$4.23M
USD
Completed NON-SBIR/STTR RPGS
A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance
NATIONAL CANCER INSTITUTE Augusta University United States 2021 – 2026

Abstract: Immunotherapy is becoming a pillar of cancer treatment, and many responsive patients have experienced durable, or even curative, outcomes. For reasons that remain unclear...

$3.45M
USD
Completed TRAINING, INDIVIDUAL
Elucidating the Role of C16orf72 in the Cellular Stress Response Network
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

PROJECT SUMMARY A hallmark of cancer is the ability of malignant cells to maintain viability in the face of stressors such as aneuploidy, nutrient scarcity, and xenobiotic compound...

$440.6K
USD
Active NON-SBIR/STTR RPGS
Longitudinal investigation of sociocultural and behavioral influences on symptom management, biological response, and functioning between Chinese and White breast cancer survivors.
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2027

PROJECT SUMMARY The number of US cancer survivors is growing rapidly, including a significant number of Chinese Americans (CA), a group with an annual breast cancer growth rate of...

$6.16M
USD
Completed NON-SBIR/STTR RPGS
A transformative drug discovery platform for allosteric kinase inhibitors
NATIONAL CANCER INSTITUTE University of Minnesota United States 2021 – 2026

Project Summary The University of Minnesota (UMN) and Photonic Pharma (PP) a Minnesota-based drug discovery start-up, have partnered to optimize, field-test, and deploy at industri...

$5.72M
USD
Completed NON-SBIR/STTR RPGS
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2023

Project Summary Metastatic colorectal cancer (mCRC) is the second leading cause of cancer-related mortality in the United States, and annually accounts for nearly 500,000 deaths wo...

$1.39M
USD
Completed NON-SBIR/STTR RPGS
TRPV1 nociceptors in oral carcinogenesis and pain
NATIONAL CANCER INSTITUTE New York University United States 2021 – 2026

Project Summary Oral cancer pain is more severe than all other cancers. Patients with metastatic oral cancer experience the greatest pain. Oral cancers activate neurons and produce...

$6.06M
USD
Active NON-SBIR/STTR RPGS
Anti-tumor potential of temperature-sensitive p53 mutants
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2027

The p53 tumor suppressor is frequently inactivated by mutations in cancer. Most p53 point mutations are located in the DNA binding domain that prevent folding or disrupt the DNA bi...

$10
USD
Active NON-SBIR/STTR RPGS
A novel strategy to overcome drug resistance in cancer
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2027

ABSTRACT The major obstacle to successful cancer therapy is the rapid development of drug resistance. While targeted therapies often extend overall survival in the subset of patien...

$4.81M
USD
Completed NON-SBIR/STTR RPGS
Multi-atlas and whole body radiomics approaches for image-guided treatment of gynecologic cancers
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2021 – 2024

ABSTRACT Gynecologic cancers are among the leading causes of cancer death in women worldwide. These patients typically are socioeconomically disadvantaged, with poor access to scre...

$2.18M
USD
Completed NON-SBIR/STTR RPGS
THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASIS
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2021 – 2026

ABSTRACT Metastasis, the primary cause of breast cancer-related mortality, is a multistep process culminating with the formation of tumor foci within distant organs. However, only...

$4.95M
USD
Active NON-SBIR/STTR RPGS
Novel inhibitor for oncogenic RAS for lung cancer
NATIONAL CANCER INSTITUTE Auburn University At Auburn United States 2021 – 2026

Project Summary/Abstract: Aberrant activation of RAS signaling is a major driver of lung cancer resulting from gain-in-function mutations in RAS genes often caused by tobacco-deriv...

$3.95M
USD
Active NON-SBIR/STTR RPGS
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

PROJECT SUMMARY Most children treated for cancer in the US will achieve long-term survival, and survivorship presents unique challenges for this growing population. Pediatric brain...

$12.78M
USD
Completed NON-SBIR/STTR RPGS
Multilevel investigation of uncertain and reclassified genomic variants in clinical oncology
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT The overarching goal of this award is to prepare the applicant for an independent, sustained program of research that incorporates psychosocial, behavioral...

$1.95M
USD
Completed NON-SBIR/STTR RPGS
The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2021 – 2026

Project Summary Our early studies have characterized IL-9-producing CD4+ T helper (Th9) cells as an antitumor T cell subset. Recently, we also revealed Th9 cells as a novel T cell...

$3.89M
USD